Wan Suriyani Wan Ibrahim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Wan Suriyani Wan Ibrahim has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Norzila Ismail
Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
2 shared publications - Siti Farhanah Mohd-Salleh
Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
2 shared publications - Harishini Rajaratinam
Faculty of Medicine, Universiti Sultan Zainal Abidin, Medical Campus, 20400 Kuala Terengganu, Terengganu, Malaysia
1 shared publication - John Ogbaji Igoli
Department of Chemistry, Joseph Sarwuan Tarka University, PMB 2372 Makurdi, Nigeria
1 shared publication - Nor Amalia Nazri
Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
1 shared publication - Nurkhalida Kamal
Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia (UKM), Bangi 43600, Malaysia
1 shared publication
Latest Publications
- Open Access
- 31 March 2026
- Published by Penerbit Universiti Sains Malaysia in Tropical Life Sciences Research
- Vol. 37 (1) , 241-271
Phytoconstituents Analysis and In Vitro Antiproliferative Activity of Abrus precatorius Leaves on Cancer Cells
Traditionally in Malaysia, the leaves of Abrus precatorius, a flowering plant that belongs to the legume family, Fabaceae, are used to treat various ailments such as coughs, diarrhoea, wound healing and even as anticancer and antivirus remedy. The study aimed to identify the phytocompounds present in A. precatorius leaves using (1) different solvents and (2) two different extraction methods for each solvent. Additionally, we have also intended to investigate the anti-proliferative activity of those maceration-based extracts on selected cancer and normal cell lines. In this study, two extraction methods were used (maceration and Soxhlet extraction), using sequential solvents according to their polarity, starting with hexane, ethyl acetate and methanol. The phytocompounds were identified via the GC-MS technique. The findings reported that the ethyl acetate extract (obtained via Soxhlet extraction) contained the highest amount of terpenoids, while the methanol extract (obtained via maceration) contained the highest combination of terpenoids and phenolic compounds. The triple negative breast cancer cell line, MDAMB-231 showed high sensitivity towards all A. precatorius leaf extracts (maceration-based). The hexane extract of A. precatorius leaves (maceration-based) showed the lowest IC50 on MDA-MB-231 cells at 80.75 ± 64.0 μg/mL. In conclusion, potential anticancer phytocompounds were identified in the A. precatorius leaves extracts such as 1-octacosanol, neophytadiene and 4-vinylphenol. All maceration-based extracts exhibited non-cytotoxicity effect on both normal breast cell MCF-10a and fibroblast cell NIH (3T3). The MDA-MB-231 cell line was the most sensitive towards all maceration-based extracts, particularly hexane-maceration based.
- 31 March 2026
- Published by Penerbit Universiti Sains Malaysia in Tropical Life Sciences Research
- Vol. 37 (1) , 241-271
Open AccessPhytoconstituents Analysis and In Vitro Antiproliferative Activity of Abrus precatorius Leaves on Cancer Cells
Traditionally in Malaysia, the leaves of Abrus precatorius, a flowering plant that belongs to the legume family, Fabaceae, are used to treat various ailments such as coughs, diarrhoea, wound healing and even as anticancer and antivirus remedy. The study aimed to identify the phytocompounds present in A. precatorius leaves using (1) different solvents and (2) two different extraction methods for each solvent. Additionally, we have also intended to investigate the anti-proliferative activity of those maceration-based extracts on selected cancer and normal cell lines. In this study, two extraction methods were used (maceration and Soxhlet extraction), using sequential solvents according to their polarity, starting with hexane, ethyl acetate and methanol. The phytocompounds were identified via the GC-MS technique. The findings reported that the ethyl acetate extract (obtained via Soxhlet extraction) contained the highest amount of terpenoids, while the methanol extract (obtained via maceration) contained the highest combination of terpenoids and phenolic compounds. The triple negative breast cancer cell line, MDAMB-231 showed high sensitivity towards all A. precatorius leaf extracts (maceration-based). The hexane extract of A. precatorius leaves (maceration-based) showed the lowest IC50 on MDA-MB-231 cells at 80.75 ± 64.0 μg/mL. In conclusion, potential anticancer phytocompounds were identified in the A. precatorius leaves extracts such as 1-octacosanol, neophytadiene and 4-vinylphenol. All maceration-based extracts exhibited non-cytotoxicity effect on both normal breast cell MCF-10a and fibroblast cell NIH (3T3). The MDA-MB-231 cell line was the most sensitive towards all maceration-based extracts, particularly hexane-maceration based.
- 21 August 2019
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 72 (5) , 826-834
Pereskia bleo Leaves Extract Induces Cell Death via Cell Cycle Arrest and Apoptosis in Cervical Cancer Cells HeLa
Introduction: Pereskia bleo is a leafy and edible plant, locally known as “Pokok Jarum Tujuh Bilah” which has anticancer properties. This study purposed to determine the cytotoxic effects of P. bleo leaves extracts on several well-known cancer cells and elucidate its underlying mechanism in inducing cell death. Methods: Cytotoxic activity on selected cell lines was determined using MTT assay. Mechanism of cell death was investigated through cell cycle and Annexin V assay. Expression of apoptotic proteins was measured by flow cytometry method. Results: Ethyl acetate extract of P. bleo leaves (PBEA) appeared to have the strongest IC50 value (14.37 ± 8.40 μg/ml) and most active against HeLa cells was further studied for apoptosis. The cell cycle investigation by flow cytometry evidenced the increment of PBEA treated HeLa cells in G0/G1 phase and apoptotic event was detected in Annexin V assay. Analysis of apoptotic protein showed pro-apoptotic proteins (Bax, p53 and caspase 3) were triggered where as anti-apoptotic protein Bcl-2 was suppressed in treated HeLa cells. Conclusions: Our findings demonstrated that PBEA treatment induced cell death in HeLa cells by p53-mediated mechanism through arresting cell cycle at G0/G1 phase and mitochondrial-mediated pathway with involvement of pro-apoptotic proteins, anti-apoptotic protein, and caspase 3.
- 21 August 2019
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 72 (5) , 826-834
Pereskia bleo Leaves Extract Induces Cell Death via Cell Cycle Arrest and Apoptosis in Cervical Cancer Cells HeLa
Introduction: Pereskia bleo is a leafy and edible plant, locally known as “Pokok Jarum Tujuh Bilah” which has anticancer properties. This study purposed to determine the cytotoxic effects of P. bleo leaves extracts on several well-known cancer cells and elucidate its underlying mechanism in inducing cell death. Methods: Cytotoxic activity on selected cell lines was determined using MTT assay. Mechanism of cell death was investigated through cell cycle and Annexin V assay. Expression of apoptotic proteins was measured by flow cytometry method. Results: Ethyl acetate extract of P. bleo leaves (PBEA) appeared to have the strongest IC50 value (14.37 ± 8.40 μg/ml) and most active against HeLa cells was further studied for apoptosis. The cell cycle investigation by flow cytometry evidenced the increment of PBEA treated HeLa cells in G0/G1 phase and apoptotic event was detected in Annexin V assay. Analysis of apoptotic protein showed pro-apoptotic proteins (Bax, p53 and caspase 3) were triggered where as anti-apoptotic protein Bcl-2 was suppressed in treated HeLa cells. Conclusions: Our findings demonstrated that PBEA treatment induced cell death in HeLa cells by p53-mediated mechanism through arresting cell cycle at G0/G1 phase and mitochondrial-mediated pathway with involvement of pro-apoptotic proteins, anti-apoptotic protein, and caspase 3.